Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Oncotarget|October 22, 2015
Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapiesSimon Gebremeskel, Brent JohnstonFrontiers in Immunology|June 16, 2015
Regulation of NKT Cell Localization in Homeostasis and InfectionDrew Slauenwhite, Brent JohnstonSeminars in Immunology|April 30, 2002
Chemokines in rapid leukocyte adhesion triggering and migrationBrent Johnston, Eugene C ButcherOncoimmunology|July 30, 2016
CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor controlLinnea Veinotte, Simon Gebremeskel, Brent JohnstonImmunology and Cell Biology|June 23, 2015
Reconstitution models to evaluate natural killer T cell function in tumor controlSimon Gebremeskel, Drew Slauenwhite, Brent JohnstonCancers|October 23, 2021
The Current Landscape of NKT Cell Immunotherapy and the Hills AheadAdam Nelson, Jordan D Lukacs, Brent JohnstonJournal of Immunology (Baltimore, Md. : 1950)|October 9, 2009
Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activationRobyn Cullen, Elitza Germanov, Takeshi Shimaoka, et al.Blood|June 19, 2002
Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacityChang H Kim, Brent Johnston, Eugene C ButcherTrends in Immunology|October 29, 2002
Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expressionChang H Kim, Eugene C Butcher, Brent JohnstonJournal for Immunotherapy of Cancer|March 5, 2022
Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regressionAdam Nelson, Simon Gebremeskel, Brian D Lichty, et al.Pageof 5